Latest news with #UniversalRegistrationDocument
Business Wire
2 days ago
- Business
- Business Wire
Teleperformance: Implementation of the Share Repurchase Program
PARIS--(BUSINESS WIRE)--Regulatory News: As part of its share repurchase program, Teleperformance (TP) (Paris:TEP) has today awarded an investment services provider a mandate to acquire its own shares, for a maximum amount of €100 million over a period starting on June 23, 2025 and extending until November 5, 2025. The shares thus repurchased are mainly intended to be allocated to the cancellation objective. The description of the share buyback program is included in the Universal Registration Document for 2024 filed with the Autorité des Marchés Financiers on March 6, 2025 (No. 25-0074). About Teleperformance Group (TP) TP (TEP – ISIN: FR0000051807 – Reuters: - Bloomberg: TEP FP) is a global leader in digital business services which consistently seeks to blend the best of advanced technology with human empathy to deliver enhanced customer care that is simpler, faster, and safer for the world's biggest brands and their customers. The Group's comprehensive, AI-powered service portfolio ranges from front office customer care to back-office functions, including operations consulting and high-value digital transformation services. It also offers a range of specialized services such as collections, interpreting and localization, visa and consular services, and recruitment process outsourcing services. The teams of multilingual, inspired, and passionate experts and advisors, spread in close to 100 countries, as well as the Group's local presence allows it to be a force of good in supporting communities, clients, and the environment. In 2024, TP reported consolidated revenue of €10,280 million (US$11 billion) and net profit of €523 million. TP shares are traded on the Euronext Paris market, Compartment A, and are eligible for the deferred settlement service. They are included in the following indices: CAC 40, STOXX 600, S&P Europe 350, MSCI Global Standard and Euronext Tech Leaders. In the area of corporate social responsibility, TP shares are included in the CAC 40 ESG since September 2022, the Euronext Vigeo Euro 120 index since 2015, the MSCI Europe ESG Leaders index since 2019, the FTSE4Good index since 2018 and the S&P Global 1200 ESG index since 2017.
Yahoo
04-06-2025
- Business
- Yahoo
Renewal of the drawdown under the Revolving Credit Facility for a six-month period
Press release 4 June 2025Renewal of the drawdown under the Revolving Credit Facility for a six-month periodParis, 4 June 2025 - Clariane ( - ISIN FR0010386334) announces that it has renewed the drawdown of its RCF (Revolving Credit Facility) for a period of 6 months for an amount of €490.8 million, in accordance with the terms of the contract signed February 14th, addition to the usual conditions, the Group points out that the drawdown and renewal of its RCF line are subject to a minimum liquidity level of €300 million on the day of the drawdown or renewal, which includes the RCF drawn down. This document contains forward-looking statements that involve risks and uncertainties, including those included or incorporated by reference, concerning the Group's future growth and profitability that could cause actual results to differ materially from those indicated in the forward-looking statements. These risks and uncertainties relate to factors that the Company cannot control or estimate precisely, such as future market conditions. The forward-looking statements made in this document constitute expectations for the future and should be regarded as such. Actual events or results may differ from those described in this document due to a number of risks and uncertainties described in Chapter 2 of the 2024 Universal Registration Document filed with the AMF on 1 April 2025 under registration number D.25-0209, available on the Company's website ( and that of the AMF ( All forward-looking statements included in this document are valid only as of the date of this press release. Clariane S.E. undertakes no obligation and assumes no responsibility to update the information contained herein beyond the requirements of applicable are cautioned not to place undue reliance on these forward-looking statements. Neither Clariane nor any of its directors, officers, employees, agents, affiliates or advisors accepts any responsibility for the reasonableness of any assumptions or opinions expressed or for the likelihood of any projections, prospects or performance being achieved. Any liability for such information is expressly excluded. Nothing in this document is, or should be construed as a promise or representation regarding the future. Furthermore, nothing contained in this document is intended to be or should be construed as a forecast of results. Clariane's past performance should not be taken as a guide to future performance. The main Alternative Performance Indicators (APIs), such as EBITDA, EBIT, net debt and financial leverage, are defined in the Universal Registration Document available on the Company's website at ClarianeClariane is the leading European community of care in times of vulnerability. It has operations in six countries: Belgium, France, Germany, Italy, the Netherlands and Spain. Relying on their diverse expertise, each year, the Group's 60,000 professionals provide services to 900,000 patients and residents in three main areas of activity: care homes (Korian, Seniors Residencias, etc.), healthcare facilities and services (Inicea, Ita, Grupo 5, etc.), and alternative living solutions (Petits-fils, Ages & Vie, etc.). In June 2023, Clariane became a purpose-driven company and added to its bylaws a new corporate purpose, common to all its activities: 'taking care of each person's humanity in times of vulnerability'.Clariane has been listed on Euronext Paris, Section B since November 2006. The Group joined the SBF 120 index and the CAC® SBT 1.5° index on 23 September ticker: - ISIN: Bisseuil Benoît Lesieur Head of Investor Relations Deputy Head of Investor Relations – ESG +33 6 58 60 68 69 +33 6 64 80 15 90 Julie Mary Florian Bachelet Press officer Press officer +33 6 59 72 50 69 +33 6 79 86 78 23 Attachment Press Release Clariane-renewal of drawdown under the RCFError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-06-2025
- Business
- Yahoo
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the 'Company'), today announced today the filing of an addendum to the 2024 Universal Registration Document (the 'Addendum') with the French market authority, 'Autorité des Marchés Financiers' ('AMF'). This Addendum provides an update to the Board of Directors' Corporate Governance Report to account for the exceptional compensation granted to the Chief Executive Officer by the Board of Directors during its meeting on April 30, 2025. The payment of this exceptional compensation remains subject to the approval of the Annual Combined General Meeting to be held on June 11, 2025. The URD and the addendum are available on the Company's website at : and on the AMF website: copies of both documents are available, free of charge, at the Company's headquarters and registered office located at 107, avenue de la République, 92320 Châtillon, France. About DBV Technologies DBV Technologies is a clinical-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with significant unmet medical need. DBV Technologies is currently focused on investigating the use of its proprietary technology platform, Viaskin, to address food allergies, which are caused by a hypersensitive immune reaction and characterized by a range of symptoms varying in severity from mild to life-threatening anaphylaxis. Millions of people live with food allergies, including young children. Through epicutaneous immunotherapy (EPIT™), the Viaskin platform is designed to introduce microgram amounts of a biologically active compound to the immune system through intact skin. EPIT is a new class of non-invasive treatment that seeks to modify an individual's underlying allergy by re-educating the immune system to become desensitized to allergen by leveraging the skin's immune tolerizing properties. DBV Technologies is committed to transforming the care of food allergic people. The Company's food allergy programs include ongoing clinical trials of Viaskin Peanut in peanut allergic toddlers (1 through 3 years of age) and children (4 through 7 years of age). DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, NJ. The Company's ordinary shares are traded on segment B of Euronext Paris (DBV, ISIN code: FR0010417345) and the Company's ADSs (each representing five ordinary shares) are traded on the Nasdaq Capital Market (DBVT – CUSIP: 23306J309). For more information, please visit and engage with us on X (formerly Twitter) and LinkedIn. Investor Contact Katie MatthewsDBV Media ContactAngela MarcucciDBV Attachment PDF VersionError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-06-2025
- Business
- Yahoo
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the 'Company'), today announced today the filing of an addendum to the 2024 Universal Registration Document (the 'Addendum') with the French market authority, 'Autorité des Marchés Financiers' ('AMF'). This Addendum provides an update to the Board of Directors' Corporate Governance Report to account for the exceptional compensation granted to the Chief Executive Officer by the Board of Directors during its meeting on April 30, 2025. The payment of this exceptional compensation remains subject to the approval of the Annual Combined General Meeting to be held on June 11, 2025. The URD and the addendum are available on the Company's website at : and on the AMF website: copies of both documents are available, free of charge, at the Company's headquarters and registered office located at 107, avenue de la République, 92320 Châtillon, France. About DBV Technologies DBV Technologies is a clinical-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with significant unmet medical need. DBV Technologies is currently focused on investigating the use of its proprietary technology platform, Viaskin, to address food allergies, which are caused by a hypersensitive immune reaction and characterized by a range of symptoms varying in severity from mild to life-threatening anaphylaxis. Millions of people live with food allergies, including young children. Through epicutaneous immunotherapy (EPIT™), the Viaskin platform is designed to introduce microgram amounts of a biologically active compound to the immune system through intact skin. EPIT is a new class of non-invasive treatment that seeks to modify an individual's underlying allergy by re-educating the immune system to become desensitized to allergen by leveraging the skin's immune tolerizing properties. DBV Technologies is committed to transforming the care of food allergic people. The Company's food allergy programs include ongoing clinical trials of Viaskin Peanut in peanut allergic toddlers (1 through 3 years of age) and children (4 through 7 years of age). DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, NJ. The Company's ordinary shares are traded on segment B of Euronext Paris (DBV, ISIN code: FR0010417345) and the Company's ADSs (each representing five ordinary shares) are traded on the Nasdaq Capital Market (DBVT – CUSIP: 23306J309). For more information, please visit and engage with us on X (formerly Twitter) and LinkedIn. Investor Contact Katie MatthewsDBV Media ContactAngela MarcucciDBV Attachment PDF VersionError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
02-06-2025
- Business
- Yahoo
PRESS RELEASE: BIGBEN: FULL YEAR 2024/25 RESULTS
Press release Lesquin, 2 June 2025 - 6pm CEST FULL YEAR 2024/25 RESULTS:DELAYS TO SEVERAL NEW RELEASES AFFECTED EARNINGS IN 2024/25 BUT WILL LEAD TO STRONG GROWTH IN 2025/26, STARTING IN THE FIRST HALF In its 2 June 2025 meeting, the Board of Directors of Bigben Interactive (ISIN FR0000074072) approved the financial statements for the year ended 31 March 2025. The Statutory Auditors' report will be issued when the Universal Registration Document is published. Consolidated IFRS figures (€ million) 2024/25 2023/24 Sales (IFRS) 288.0 292.0 Gross profit 147.4 142.548.8% EBITDA before non-recurring items 62.1 62.0 Non-recurring items (1.0) 16.0 EBITDA 61.1 78.0 Operating income (2.0) 23.8 Net financial income/(expense) (1.3) (3.6) Profit before tax (3.3) 20.1 Income tax 3.0 0.8 Net income for the period (0.3) 21.0 The Bigben group generated sales of €288.0 million in the 2024/25 financial year. Of this, NACON contributed €167.9 million and Bigben AudioVideo/Telco €120.0 million. Gross margin was 51.2%, up 2.4 points year-on-year because of improvements in the product mix. EBITDA before non-recurring items was €62.1 million, stable relative to the previous year. Non-recurring items included the impact of a tax dispute inherited when the Group acquired ModeLabs in 2011 (appeals ongoing) and reversals of earn-out provisions at NACON. Net financial income/(expense) included an IFRS capital gain of €8.3 million arising from the cancellation of exchangeable bonds bought back during the year. Analysis of performance by business NACON Bigben AudioVideo/Telco Consolidated IFRS figures (€ million) 2024/25 2023/24 2024/25 2023/24 Sales 167.9 167.7 120.0 124.3 Gross profit 108.1 104.2 39.2 38.3 EBIDTA before non-recurring items 55.9 56.7 5.9 5.1 EBITDA 59.7 70.9 1.4 7.1 Operating income 1.1 20.9 -3.1 2.9 NACON GAMING. After NACON postponed the launch of several games and accessories until the 2025/26 financial year, its sales amounted to €167.9 million in full-year 2024/25, stable year-on-year. Sales totalled €97.1 million in Gaming, €65.2 million in Accessories and €5.6 million in other activities. Gross margin improved to 64.4% as opposed to 62.1% in the 2023/24 financial year. Ebitda before non-recurring items was stable at €55.9 million. The release of Test Drive Unlimited during the year caused depreciation/amortisation of non-current assets to increase by €8.5 million year-on-year to €58.5 million. Operating income was €1.1 million. Higher interest rates explain the change in net financial expense: the current average interest rate on bank borrowings is 3.0%. Exchange differences remained stable (foreign exchange loss of €1.1 million versus a loss of €0.8 million in the previous year). Bigben AudioVideo/Telco generated sales of €120.0 million as opposed to €124.3 million a year previously. The business was solid despite the sluggish market, with sales down only slightly to €93.1 million. The business generated sales of €26.9 million. Gross margin increased to 32.7% because of better control over procurement and a product mix that was more helpful in driving sales. EBITDA totalled €1.4 million, hampered by a tax dispute dating from 2011 in relation to the ModeLabs acquisition, in which the Group has filed several appeals. After a judgment on 9 May 2025, a non-recurring expense has been recognised, with no cash impact, in the net amount of the tax receivable previously recognised, i.e. €4.6 million. However, the Group intends to continue asserting its rights and has decided to refer the matter to the European Court of Human Rights. After net financial income of €4.5 million and a tax expense of €0.4 million, net income amounted to €1.0 million during the year. Consolidated balance sheet At 31 March 2025, the Bigben group had equity of €338.9 million, including €9 million arising from NACON's capital increase in July 2024. Available cash amounted to €45.3 million as opposed to €41.2 million at 31 March 2024. Net debt amounted to €159.3 million, including Bigben's bond debt, which has a carrying amount of €62.2 million in the consolidated financial statements. Funds from operations totalled €63.7 million during the first-half period. Dividend: The Board of Directors decided in its 2 June 2025 meeting not to propose a dividend with respect to the 2024/25 financial year in its upcoming Shareholders' General Meeting. 2025/26: Strong growth in business levels and operating income starting in the first half NACON Gaming business: The 2025/26 line-up of games presented during Bigben Week 2025 included around 15 games. The release schedule will be busy in the first half of the financial year (1 April - 30 September), including the release of several major games: Adventure: After winning over fans with in 2023, Robocop is making a comeback in which is scheduled for release on 17 July. another hotly anticipated game, will be available from 4 September 2025. Sport: which came out in early May and has already racked up impressive sales figures . Racing: Season 4 of featuring a casino. Simulation: and downloadable content (DLC) relating to several successful games Releases scheduled for the second half of the financial year (1 October - 31 March) are: Adventure: Sport: . Racing: , and seasons 5 and 6 of Because of the number of games released in 2024/25, Back Catalogue sales in 2025/26 are likely to be similar to the level achieved last year. NACON has also just announced a new agreement with WRC Promoter in relation to the World Rally Championship (WRC) licence. The licence covers the development and publication of games and official WRC eSports competitions, and gives NACON exclusive rights on PC and consoles for six seasons from 2027 to 2032. Accessories business: Performance in the current year will also be supported by the launch of new accessories, confirming the expertise acquired by NACON in this area: Since it was released on 23 April, the controller has been getting rave reviews from industry figures. It has achieved an average rating of 9/10 in the specialist press. The range has just been launched with the RS Pure steering wheel, the DD-9Nm base and the RS Pure pedal set. For the release of the Nintendo SwitchTM2, NACON has developed around 30 accessories specifically for the console. BIGBEN AUDIOVIDEO/TELCO Mobile Accessories business: Although the market remains difficult (sales down 10% in the first quarter of 2025), Bigben is likely to continue benefiting in 2025/26 from the strategy it has developed in recent years, consisting of diversifying across multiple product areas and sales channel. This strategy is already paying off handsomely, as shown by: The performance and brand strength of the ® range, which is enabling Bigben to expand and bolster its market shares. Several new products have recently been launched under the ® brand, such as a new Air Xtrem case, smart trackers, Play earphones, surge protection power strips and 5-zone travel chargers. Recently launched products are proving highly successful. This is the case with ® headsets, Bigben® smart watches and Origine France Garantie chargers. The expansion of Bigben's distribution channels is continuing, with products now available in many new points of sale in segments including DIY stores and service stations. Bigben is also carrying out extensive work to optimise and secure its supply chain, and this is also allowing it to reduce carbon emissions with the development of the Origine France Garantie label. Audio/Video: To continue the development of this business, Bigben is relying on the diversification of its points of sale, the strong brand recognition achieved by the Cosy Thomson range and the launch of new products with the expansion of the Hi Buddies range, the development of products featuring 1980s design under the EPOK brand, but also the launch in autumn 2025 of the first BLUEY™ alarm clock/nightlight under licence from BBC Studios. Bigben is continuing to have its ® and products listed by new retailers and distributed via METRONIC in Europe (France, Italy, Spain and Portugal). With Bigben AudioVideo/Telco's business levels likely to be highly resilient and NACON expected to see strong sales growth, the Group is going into the 2025/26 financial year with confidence, buoyed by a stronger product line-up, a strategy of continuous innovation and rigorous financial discipline. Next event: Shareholders' General Meeting, 25 July 2025 First-quarter 2025/26 sales: 28 July 2025 after the market close ABOUT BIGBEN INTERACTIVE 2024/25 IFRS SALES: €288 million WORKFORCEOver 1,300 employees INTERNATIONAL PRESENCE36 subsidiaries and a distribution network covering more than 100 Bigben is a pan-European player in publishing video games and designing and distributing mobile accessories, gaming accessories and audio/video products. The Group is known for being innovative and creative, and aims to be one of Europe's leading companies in each of its markets. Listed on Euronext Paris, compartment B – Index: CAC Mid & Small – Eligible for the long-only deferred settlement serviceISIN: FR0000074072; Reuters: BIGPA; Bloomberg: BIGFP PRESS CONTACTCap Value – Gilles Broquelet gbroquelet@ - +33 (0)1 80 81 50 01 Attachment CP_BBI_RA 2024_25 Diffusion EnglishError in retrieving data Sign in to access your portfolio Error in retrieving data
